Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia

被引：0
|
作者：
Farnier, M. [1 ]
Guyton, J. R. [2 ]
Jensen, E. [3 ]
Polis, A. [3 ]
Johnson-Levonas, A. O. [3 ]
Brudi, P. [3 ]
机构：
[1] Point Med, Dijon, France
[2] Duke Univ, Med Ctr, Durham, NC 27706 USA
[3] Merck Sharp & Dohme Corp, Whitehouse Stn, NJ USA
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：281 / 282
页数：2
相关论文
共 50 条
  • [1] Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia
    Farnier, Michel
    Guyton, John R.
    Jensen, Erin
    Polis, Adam B.
    Johnson-Levonas, Amy O.
    Brudi, Philippe
    ATHEROSCLEROSIS, 2013, 229 (02) : 415 - 422
  • [2] Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease
    Vaverkova, Helena
    Farnier, Michel
    Averna, Maurizio
    Missault, Luc
    Viigimaa, Margus
    Dong, Qian
    Shah, Arvind
    Johnson-Levonas, Amy O.
    Brudi, Philippe
    CLINICAL BIOCHEMISTRY, 2011, 44 (8-9) : 627 - 634
  • [3] INFLUENCE OF FENOFIBRATE, SIMVASTATIN AND/OR EZETIMIBE ON CORRELATION OF LDL AND NON- HDL CHOLESTEROL WITH APOLIPOPROTEIN B IN MIXED DYSLIPIDEMIC PATIENTS
    Farnier, M.
    Taggart, W.
    Dong, Q.
    Shah, A.
    Brudi, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 68 - 68
  • [4] Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia
    Farnier, Michel
    Chen, Erluo
    Johnson-Levonas, Amy O.
    Sisk, Christine McCrary
    Mitchel, Yale B.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 279 - 290
  • [5] Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia
    Assmann, Gerd
    Kannenberg, Frank
    Ramey, Dena R.
    Musliner, Thomas A.
    Gutkin, Stephen W.
    Veltri, Enrico P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (01) : 249 - 259
  • [6] Ezetimibe/simvastatin combination reduces LDL cholesterol
    不详
    FORMULARY, 2004, 39 (04) : 199 - 200
  • [7] Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia
    Davidson, MH
    McGarry, T
    Bettis, R
    Melani, L
    Lipka, LJ
    LeBeaut, AP
    Suresh, R
    Sun, S
    Veltri, EP
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (12) : 2125 - 2134
  • [8] Comparison of Effects of Morning Versus Evening Administration of Ezetimibe/Simvastatin on Serum Cholesterol in Patients with Primary Hypercholesterolemia
    Yoon, Hyung Sik
    Kim, Sung Ho
    Kim, Jeong Kyung
    Ko, Sang Hun
    Ko, Jae Ee
    Park, Soo Jin
    Park, Moon Gi
    Lee, Jae Hwan
    Hyon, Min Soo
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (7-8) : 841 - 849
  • [9] Effects of ezetimibe/simvastatin on lipoprotein subclasses in patients with primary hypercholesterolemia
    Ose, L.
    Olegario, K. Q.
    Reyes, R.
    Johnson-Levonas, A. O.
    Sapre, A.
    Tribble, D.
    EUROPEAN HEART JOURNAL, 2006, 27 : 945 - 945
  • [10] Effects of ezetimibe and simvastatin, coadministered and alone, on the kinetics of apolipoprotein B-48 in patients with primary hypercholesterolemia
    Tremblay, Andre J.
    Lamarche, Benoit
    Hogue, Jean-Charles
    Couture, Patrick
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E64 - E64
12345